7 Related NICE guidance
Published
-
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer. NICE technology appraisal guidance 214 (2011).
-
Advanced breast cancer: diagnosis and management. NICE clinical guideline 81 (2009).
-
Gemcitabine for the treatment of metastatic breast cancer. NICE technology appraisal guidance 116 (2007).